Thursday, May 29, 2025

Latest

Biotech Firm AN2 Therapeutics Prices US$69 Million IPO

Biopharmaceutical company AN2 Therapeutics, Inc. (Nasdaq: ANTX) began trading on the Nasdaq Global Select Market today. The firm’s initial public offering is looking to raise US$69.0 million and is expected to close on March 29, 2022.

The offering consists of 4.6 million common shares, upsized from 4.0 million shares, selling at US$15.00 per share. The company intends to use the proceeds to fund the clinical development and expansion of its drug candidate epetraborole, and for general corporate purposes, including working capital and operating expenses.

Cowen, SVB Leerink, and Evercore ISI act as the joint bookrunners for the said offering. The underwriters were granted a 30-day over-allotment option to purchase additional 690,000 shares at the same IPO price.

The Menlo Park-based biotech company is focused on developing epetraborole, an experimental oral treatment for patients with chronic non-tuberculous mycobacterial lung disease.

LOGO

Information for this briefing was found via Edgar and the companies mentioned. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Leave a Reply

Video Articles

How To Profit From $3300 Gold? An Inside Look At A Massive 300,000 Oz Project | Martino De Ciccio

We’re At The Start of a Great Silver Boom | Ross McElroy & Andy Bowering – Apollo Silver Corp

Equinox Gold Q1 Earnings: When Everything Goes Wrong

Recommended

Sterling Metals Hits 0.21% Copper Over 482.8 Metres In First Drilling At Soo Copper project

First Majestic Makes Second Major Discovery At Santa Elena In Just A Year

Related News

DigitalOcean: The IPO Deep Dive

DigitalOcean (NYSE: DOCN) is a cloud infrastructure provider, with its headquarters located in New York...

Wednesday, March 24, 2021, 12:30:00 PM

Cannabis SPAC Relativity Acquisition Prices US$125 Million IPO

Special purpose acquisition company Relativity Acquisition Corp. (Nasdaq: RACYU) started trading its securities on the...

Friday, February 11, 2022, 02:17:00 PM

Payfare Completes $65.4 Million IPO, To Begin Trading This Morning

Payfare Inc (TSX: PAY) has completed its initial public offering this morning, raising gross proceeds...

Friday, March 19, 2021, 09:25:08 AM

Fintech Firm-Backed SPAC FTAC Emerald Acquisition Prices US$220 Million IPO

Special purpose acquisition company FTAC Emerald Acquisition Corp. (Nasdaq: EMLDU) started trading publicly on the...

Thursday, December 16, 2021, 02:22:00 PM

$BABY: Weak Demand For IPO Caused Debuting Nasdaq Stock To Fail On Trading Day

PishPosh, a small baby-goods shop that wanted to list under the ticker BABY, had its...

Saturday, March 11, 2023, 01:42:00 PM